MT1 10mg

£44.90

If you are looking to buy MT1 peptide in the UK, VITALA’s MT1 10mg vial is one of the most carefully formulated research-grade options available from a domestic UK supplier today. MT1, commonly known as Melanotan 1 or Afamelanotide, is a synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH) — a naturally occurring peptide that plays a central role in regulating skin pigmentation, photoprotection, and a range of broader physiological processes. It was one of the earliest melanocortin peptides to be developed and studied, and it remains one of the most well-characterised compounds in melanocortin receptor research today.

Store it in a laboratory refrigerator at 2°C to 8°C before reconstitution. Once reconstituted, keep the solution refrigerated and use it within the recommended stability timeframe for bacteriostatic water-stabilised peptides. Do not freeze the reconstituted solution.

Yes. MT1 (Melanotan 1 / Afamelanotide) is available to purchase directly from Peptide Shop UK as part of the VITALA research range. We provide high-purity, HPLC-verified peptides with fully tracked domestic delivery throughout the UK.

Yes. MT1 is legal to purchase in the UK for Research and Development purposes. It is not intended for human consumption or medical treatment and must only be used within a controlled, registered laboratory environment in accordance with applicable UK regulations.

MT1 and MT2 are both synthetic melanocortin peptides derived from α-MSH, but they have distinctly different receptor profiles and research applications. MT1 is highly selective for MC1R and is primarily studied for its effects on skin pigmentation, photoprotection, and dermatological conditions. MT2 is a broader melanocortin agonist that also activates MC3R and MC4R receptors, giving it additional effects on sexual arousal, energy balance, and appetite — which is why PT-141 (Bremelanotide), a closely related compound, is studied specifically for its central effects on desire and arousal. Researchers choose between them depending on which receptor pathways and physiological effects they are investigating.

 Melanogenesis is the biological process by which melanocytes produce melanin — the pigment that gives skin, hair, and eyes their colour and provides the skin's primary natural defence against UV radiation. Understanding how melanogenesis is regulated at a molecular level is important for research into photoprotection, photosensitivity disorders, pigmentation diseases, and skin cancer biology. MT1's clean activation of MC1R makes it one of the most useful tools available for studying this process in a controlled setting.

Erythropoietic Protoporphyria (EPP) is a rare genetic disorder that causes extreme sensitivity to light, resulting in severe pain and skin damage upon even brief sun exposure. MT1 has been studied in EPP models because its ability to increase melanin production in the skin may offer a degree of photoprotection that reduces light sensitivity. This has made MT1 one of the most clinically relevant melanocortin peptides in rare disease and photodermatology research.

MT1 has been studied for its role in supporting increased melanin production, enhanced skin pigmentation, improved photoprotection against UV-related DNA damage, anti-inflammatory activity in skin tissue, modulation of melanocortin receptor pharmacology, and broader immune system effects through peripheral MC1R activation. Its high MC1R selectivity and well-established research profile make it one of the most reliable and thoroughly characterised melanocortin peptides available for study today.

Description

Product Information

If you are looking to buy MT1 peptide in the UK, VITALA’s MT1 10mg vial is one of the most carefully formulated research-grade options available from a domestic UK supplier today.

MT1, commonly known as Melanotan 1 or Afamelanotide, is a synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH) — a naturally occurring peptide that plays a central role in regulating skin pigmentation, photoprotection, and a range of broader physiological processes. It was one of the earliest melanocortin peptides to be developed and studied, and it remains one of the most well-characterised compounds in melanocortin receptor research today.

What makes MT1 particularly interesting as a research compound is the breadth of systems it touches. By activating melanocortin receptors — particularly MC1R in the skin — it triggers melanogenesis, the process by which the skin produces and distributes melanin. This gives researchers a highly controlled and well-understood tool for studying pigmentation biology, photoprotection, and the broader downstream effects of melanocortin receptor activation.

MT1 supports increased melanin production, enhanced skin pigmentation, improved photoprotection against UV-related damage, and anti-inflammatory effects at the skin level. It has also been studied for its influence on energy balance, libido, and immune modulation — making it one of the more broadly applicable melanocortin peptides in current research.

VITALA’s MT1 10mg vial gives UK researchers a stable, high-purity lyophilised compound that is straightforward to reconstitute and consistent to work with across a wide range of dermatological and melanocortin receptor study protocols.

Research Focus

MT1 occupies a well-established and still-expanding space in peptide research. Its selectivity for MC1R makes it a cleaner research tool than some broader melanocortin agonists, while its well-documented effects on pigmentation and photoprotection give researchers a reliable and reproducible model to work from.

In UK laboratory settings, the VITALA MT1 10mg vial is currently being used to explore:

Melanogenesis and Skin Pigmentation: MT1 activates MC1R receptors on melanocytes, triggering the production and redistribution of eumelanin — the dark pigment responsible for skin and hair colouration. Researchers are studying the precise signalling pathways involved in this process and how different levels of MC1R activation influence the rate and distribution of melanin synthesis.

Photoprotection and UV Defence: One of the most important research areas for MT1 involves its ability to enhance the skin’s natural defences against ultraviolet radiation. By stimulating melanin production, MT1 increases the skin’s capacity to absorb and neutralise UV rays before they can cause DNA damage to skin cells. Studies are examining the magnitude of this protective effect and its relevance to photodermatology research.

Erythropoietic Protoporphyria (EPP) Models: MT1 has been studied extensively in models of EPP — a rare and painful photosensitivity disorder caused by the accumulation of protoporphyrin IX in red blood cells. Researchers are investigating how MC1R activation and increased melanin production can reduce photosensitivity and improve light tolerance in EPP research models.

Anti-Inflammatory Effects: Beyond pigmentation, MC1R activation by MT1 has demonstrated meaningful anti-inflammatory properties. Researchers are studying how it modulates cytokine expression and inflammatory signalling in skin tissue, and whether these effects extend to systemic anti-inflammatory activity.

Melanocortin Receptor Pharmacology: MT1’s high selectivity for MC1R makes it a valuable tool for mapping melanocortin receptor pharmacology. Researchers are using it to study MC1R binding kinetics, downstream signalling cascades, and how MC1R activity compares and interacts with other melanocortin receptor subtypes.

Energy Balance and Metabolic Effects: MC1R is not exclusively expressed in the skin. Studies are exploring MT1’s effects on energy homeostasis and metabolic regulation through peripheral melanocortin receptor activity, adding a metabolic dimension to what is primarily understood as a dermatological compound.

Immune System Modulation: Melanocortin receptors are expressed on various immune cells. Researchers are investigating how MT1-driven MC1R activation influences immune cell behaviour, cytokine release, and the broader immunomodulatory properties of the melanocortin system.

Composition of the MT1 Research Vial

VITALA MT1 is a single-compound research vial, giving researchers a focused and well-characterised tool for studying this α-MSH analogue in a controlled laboratory setting.

MT1 (Melanotan 1 / Afamelanotide): 10mg — A linear synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH), with a modified amino acid sequence that improves its stability and extends its half-life compared to native α-MSH. MT1 acts primarily as an agonist at the MC1R melanocortin receptor on melanocytes, stimulating melanogenesis and increasing eumelanin production in skin tissue. It supports increased melanin synthesis, enhanced skin pigmentation, improved photoprotection against UV radiation, anti-inflammatory activity at the skin level, and broader melanocortin receptor modulation across peripheral tissues.

The compound is supplied as a lyophilised (freeze-dried) powder. It requires reconstitution with bacteriostatic water under sterile laboratory conditions before use. This format ensures peptide stability during transit and provides an extended shelf life when stored at the correct temperature.

Why Choose VITALA MT1 from Peptide Shop UK

Melanocortin receptor research demands a compound you can rely on completely. Every VITALA MT1 10mg vial is independently tested and confirmed to a purity of greater than 98% using High-Performance Liquid Chromatography (HPLC). That level of verification means every vial delivers exactly what is stated — the same quality, the same standard, every single order.

Each vial is sealed under sterile manufacturing conditions, protecting the peptide from contamination before it arrives at your laboratory. Whether you are studying pigmentation biology, photoprotection mechanisms, or the broader pharmacology of the melanocortin system, you get a compound that performs consistently and reliably from the first study to the last.

For UK researchers who need to buy MT1 Melanotan 1 peptide from a trustworthy domestic source, Peptide Shop UK offers fast tracked delivery, transparent purity documentation, and a research-grade product range designed around the needs of the UK scientific community.

Product Specifications

Product Name: MT1 (Melanotan 1 / Afamelanotide) Format: Lyophilised Powder – Injectable Vial Total Peptide Content: 10mg Purity: >98% (HPLC Verified) Reconstitution: Bacteriostatic Water Required Intended Use: Research & Development Only

Storage and Laboratory Handling

Storing your MT1 vial correctly is simple. Before reconstitution, keep the vial refrigerated at between 2°C and 8°C and away from direct sunlight. Do not freeze the lyophilised powder as this can compromise the structural integrity of the peptide.

Once reconstituted with bacteriostatic water, store the solution in the refrigerator and use it within the recommended stability window for bacteriostatic peptide preparations. Always replace the cap firmly after each laboratory use to maintain a sterile research environment and protect the remaining compound.

Regulatory Status in the UK

MT1 (Melanotan 1 / Afamelanotide) is sold strictly for Research and Development (R&D) use within the United Kingdom. It is not a licensed medicinal product and is not approved for human consumption or clinical administration. All research involving this compound must be conducted within a registered laboratory setting and in full compliance with applicable UK regulations.

Who Is This Product For

VITALA MT1 10mg is intended for UK-based dermatologists, pharmacologists, biochemists, and qualified laboratory professionals actively working in the fields of melanocortin receptor research, pigmentation biology, photodermatology, immunology, and peptide pharmacology. It is not suitable for personal use or self-administration.

Shipping and Delivery

All VITALA orders placed through Peptide Shop UK are dispatched domestically via Royal Mail Tracked Delivery. Your vials are carefully packaged to protect lyophilised compounds throughout the delivery journey. Most UK orders arrive within 2 to 4 working days from the date of dispatch — keeping your research on schedule without unnecessary delays.

All peptides sold by Peptide Shop UK under the VITALA brand are intended for Research and Development (R&D) purposes only.

Reviews

There are no reviews yet.

Be the first to review “MT1 10mg”

Your email address will not be published. Required fields are marked *